We are live on ! Find out more
IRD

Opus Genetics
IRD

18 hedge funds and large institutions have $2.21M invested in Opus Genetics in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

5% less capital invested

Capital invested by funds: $2.34M → $2.21M (-$128K)

10% less funds holding

Funds holding: 20 → 18 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$14.1K
2
U
UBS
Switzerland
+$7.81K
3
Citigroup
Citigroup
New York
+$1.27K
4
GC
Guggenheim Capital
Illinois
+$1.06K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$845

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.01M
2
VKH
Virtu KCG Holdings
New York
-$33K
3
Citadel Advisors
Citadel Advisors
Florida
-$19K
4
Nomura Holdings
Nomura Holdings
Japan
-$12K
5
WA
WFG Advisors
Texas
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.01M – – –
SFM
2
Sphera Funds Management
Israel
$765K +$660K +3,125 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$141K – – –
Nomura Holdings
4
Nomura Holdings
Japan
$55K -$12K -57 -20%
Northern Trust
5
Northern Trust
Illinois
$47K – – –
BMC
6
Benin Management Corp
Connecticut
$42K – – –
Bank of America
7
Bank of America
North Carolina
$26K +$211 +1 +1%
Goldman Sachs
8
Goldman Sachs
New York
$21K – – –
GC
9
Guggenheim Capital
Illinois
$21K +$1.06K +5 +6%
State Street
10
State Street
Massachusetts
$18K – – –
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$17K – – –
Morgan Stanley
12
Morgan Stanley
New York
$17K +$14.1K +67 New
U
13
UBS
Switzerland
$10K +$7.81K +37 +1,850%
BA
14
BlackRock Advisors
Delaware
$9K – – –
Citigroup
15
Citigroup
New York
$6K +$1.27K +6 +40%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$2K +$845 +4 +80%
Canada Life
17
Canada Life
Manitoba, Canada
$1K – – –
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
SM
19
Sabby Management
Florida
– -$1.01M -4,689 Closed
VKH
20
Virtu KCG Holdings
New York
– -$33K -152 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$19K -88 Closed
WA
22
WFG Advisors
Texas
– -$9K -42 Closed

IRD Hedge Fund Activity: Q4 2013 in Review

18 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2013, worth a combined $2.21M — down 5.5% from $2.34M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IRD and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $14.1K. The largest seller was Sabby Management, exiting entirely with an estimated $1.01M sold.

  • 18 institutional investors held Opus Genetics (IRD) as of Q4 2013, down from 20 in Q3 2013.
  • Funds reported $2.21M of Opus Genetics stock for Q4 2013, down 5.5% quarter-over-quarter.
  • 2 funds opened new Opus Genetics positions in Q4 2013 and 4 closed out, a net change of -2 holders.
  • The largest Opus Genetics buyer in Q4 2013 was Morgan Stanley, an estimated $14.1K added.
  • The largest Opus Genetics seller in Q4 2013 was Sabby Management, an estimated $1.01M sold.

Based on aggregated 13F filings for Q4 2013.